{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:19:15Z","timestamp":1761167955130,"version":"build-2065373602"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R41 HL142451-01A1"],"award-info":[{"award-number":["R41 HL142451-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010260","name":"Union for International Cancer Control","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010260","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The use of recombinant growth factors has led to improved hematopoietic function after chemotherapy, but hematologic and immune complications still occur after chemotherapy which can be life-threatening. Here we show that pan-SHIPi compounds can induce endogenous G-CSF and TPO production in vivo and can also increase host survival after a lethal fungal challenge. In addition, we show that consistent with their ability to induce G-CSF, pan-SHIPi compounds can promote increased granulopoiesis in normal mice and speed recovery of neutrophil counts after chemotherapy. We also report the identification of a novel SHIP1-selective inhibitor, A32, that also increases steady state production of both G-CSF and TPO. These findings indicate small molecule inhibitors of SHIP1 can promote hematologic recovery after myeloablative chemotherapy and are a unique means to induce endogenous production of multiple growth factors that promote hematologic recovery.<\/jats:p>","DOI":"10.1186\/s10020-025-01383-3","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:11:52Z","timestamp":1761041512000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SHIPi improves hematologic recovery after chemotherapy"],"prefix":"10.1186","volume":"31","author":[{"given":"Sandra","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Pedicone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otto M.","family":"Dungan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Pacherille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shea T.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn","family":"Dormann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"del Fresno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Sancho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie","family":"Toms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denzil","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William G.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"1383_CR1","doi-asserted-by":"publisher","first-page":"107602962110055","DOI":"10.1177\/10760296211005555","volume":"27","author":"HAW Ahmed","year":"2021","unstructured":"Ahmed HAW, et al. Eltrombopag effectiveness and tolerability in chronic immune thrombocytopenia: a meta-analysis. Clin Appl Thromb Hemost. 2021;27:10760296211005556.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"1383_CR2","doi-asserted-by":"publisher","first-page":"7526","DOI":"10.1038\/s41598-024-54655-z","volume":"14","author":"AP Atomwise","year":"2024","unstructured":"Atomwise AP. AI is a viable alternative to high throughput screening: a 318-target study. Sci Rep. 2024;14(1):7526.","journal-title":"Sci Rep"},{"issue":"7","key":"1383_CR3","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.4049\/jimmunol.0902844","volume":"184","author":"R Brooks","year":"2010","unstructured":"Brooks R, et al. SHIP1 inhibition increases immunoregulatory capacity and triggers apoptosis of hematopoietic cancer cells. J Immunol. 2010;184(7):3582\u20139.","journal-title":"J Immunol"},{"issue":"W1","key":"1383_CR4","doi-asserted-by":"publisher","first-page":"W324","DOI":"10.1093\/nar\/gkae300","volume":"52","author":"M Bugnon","year":"2024","unstructured":"Bugnon M, et al. Swissdock 2024: major enhancements for small-molecule docking with attracting cavities and autodock vina. Nucleic Acids Res. 2024;52(W1):W324\u201332.","journal-title":"Nucleic Acids Res"},{"key":"1383_CR5","doi-asserted-by":"publisher","first-page":"156373","DOI":"10.1016\/j.cyto.2023.156373","volume":"171","author":"BP Chowdhury","year":"2023","unstructured":"Chowdhury BP, et al. SHIP1 inhibition via 3-alpha-amino-cholestane enhances protection against Leishmania infection. Cytokine. 2023;171:156373.","journal-title":"Cytokine"},{"issue":"3","key":"1383_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40588-018-0098-6","volume":"5","author":"JV Desai","year":"2018","unstructured":"Desai JV, Lionakis MS. The role of neutrophils in host defense against invasive fungal infections. Curr Clin Microbiol Rep. 2018;5(3):181\u20139.","journal-title":"Curr Clin Microbiol Rep"},{"issue":"8","key":"1383_CR7","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, et al. AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings. J Chem Inf Model. 2021;61(8):3891\u20138.","journal-title":"J Chem Inf Model"},{"key":"1383_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27238451","author":"S Fernandes","year":"2022","unstructured":"Fernandes S, et al. N1-benzyl tryptamine pan-SHIP1\/2 inhibitors: synthesis and preliminary biological evaluation as anti-tumor agents. Molecules. 2022. https:\/\/doi.org\/10.3390\/molecules27238451.","journal-title":"Molecules"},{"issue":"13","key":"1383_CR9","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1182\/blood-2008-02-138008","volume":"113","author":"AL Hazen","year":"2009","unstructured":"Hazen AL, et al. SHIP is required for a functional hematopoietic stem cell niche. Blood. 2009;113(13):2924\u201333.","journal-title":"Blood"},{"issue":"11","key":"1383_CR10","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1101\/gad.12.11.1610","volume":"12","author":"CD Helgason","year":"1998","unstructured":"Helgason CD, et al. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev. 1998;12(11):1610\u201320.","journal-title":"Genes Dev"},{"issue":"2","key":"1383_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1086\/317943","volume":"183","author":"K Hubel","year":"2001","unstructured":"Hubel K, et al. Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases. J Infect Dis. 2001;183(2):321\u20138.","journal-title":"J Infect Dis"},{"key":"1383_CR12","doi-asserted-by":"crossref","unstructured":"Iyer, S., R. Brooks, M. Gumbleton, and W. G. Kerr. SHIP1-expressing mesenchymal stem cells regulate hematopoietic stem cell homeostasis and lineage commitment during aging. Stem Cells and Development.\u00a02015a;24:1073\u20131081. PMID: 24857423","DOI":"10.1089\/scd.2014.0501"},{"key":"1383_CR13","doi-asserted-by":"crossref","unstructured":"Iyer, S., Brooks, R., Gumbleton, M. and Kerr, W.G. SHIP1-expressing mesenchymal stem cells regulate HSC homeostasis and lineage choice during aging. Stem Cells and Development. 2015b;24:1073-81. PMID: 25525673","DOI":"10.1089\/scd.2014.0501"},{"key":"1383_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2010.05869.x","volume":"1217","author":"WG Kerr","year":"2011","unstructured":"Kerr WG. Inhibitor and activator: dual functions for SHIP in immunity and cancer. Ann N Y Acad Sci. 2011;1217:1\u201317.","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"1383_CR15","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJM198709103171107","volume":"317","author":"HL Malech","year":"1987","unstructured":"Malech HL, Gallin JI. Current concepts: immunology. Neutrophils in human diseases. N Engl J Med. 1987;317(11):687\u201394.","journal-title":"N Engl J Med"},{"issue":"8","key":"1383_CR16","doi-asserted-by":"publisher","first-page":"e202400597","DOI":"10.1002\/cmdc.202400597","volume":"20","author":"AM Pacherille","year":"2025","unstructured":"Pacherille AM, et al. Aminocholestane and aminoandrostane inhibitors of the SH2 domain-containing inositol 5\u2019-phosphatase (SHIP). ChemMedChem. 2025;20(8):e202400597.","journal-title":"ChemMedChem"},{"key":"1383_CR17","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.238030","author":"C Pedicone","year":"2020","unstructured":"Pedicone C, et al. Pan-SHIP1\/2 inhibitors promote microglia effector functions essential for CNS homeostasis. J Cell Sci. 2020. https:\/\/doi.org\/10.1242\/jcs.238030.","journal-title":"J Cell Sci"},{"issue":"4","key":"1383_CR18","doi-asserted-by":"publisher","first-page":"104170","DOI":"10.1016\/j.isci.2022.104170","volume":"25","author":"C Pedicone","year":"2022","unstructured":"Pedicone C, et al. Discovery of a novel SHIP1 agonist that promotes degradation of lipid-laden phagocytic cargo by microglia. iScience. 2022;25(4):104170.","journal-title":"iScience"},{"issue":"12","key":"1383_CR19","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1021\/acs.jcim.3c00054","volume":"63","author":"UF Rohrig","year":"2023","unstructured":"Rohrig UF, et al. Attracting cavities 2.0: improving the flexibility and robustness for small-molecule docking. J Chem Inf Model. 2023;63(12):3925\u201340.","journal-title":"J Chem Inf Model"},{"issue":"1 Suppl","key":"1383_CR20","first-page":"4","volume":"17","author":"ME Rostad","year":"1990","unstructured":"Rostad ME. Management of myelosuppression in the patient with cancer. Oncol Nurs Forum. 1990;17(1 Suppl):4\u20138.","journal-title":"Oncol Nurs Forum"},{"issue":"Suppl 1","key":"1383_CR21","first-page":"S96","volume":"1","author":"S Vadhan-Raj","year":"2003","unstructured":"Vadhan-Raj S. Future directions with hematopoietic growth factors. J Natl Compr Canc Netw. 2003;1(Suppl 1):S96-101.","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"1383_CR22","first-page":"137","volume":"4","author":"S Vadhan-Raj","year":"2005","unstructured":"Vadhan-Raj S, Cohen V, Bueso-Ramos C. Thrombopoietic growth factors and cytokines. Curr Hematol Rep. 2005;4(2):137\u201344.","journal-title":"Curr Hematol Rep"},{"key":"1383_CR23","doi-asserted-by":"publisher","unstructured":"Brooks, S. Iyer, H. Akada, S. Neelam, C. M. Russo, J. D. Chisholm, W. G. Kerr. Coordinate expansion of murine hematopoietic and mesenchymal stem cell compartments by SHIPi. Stem Cells. 2015;33:(3):848\u201358. https:\/\/doi.org\/10.1002\/stem.1902R.","DOI":"10.1002\/stem.1902R"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01383-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-025-01383-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01383-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:04:21Z","timestamp":1761087861000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-025-01383-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1383"],"URL":"https:\/\/doi.org\/10.1186\/s10020-025-01383-3","relation":{},"ISSN":["1528-3658"],"issn-type":[{"type":"electronic","value":"1528-3658"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All studies using mice were approved by the IACUC at SUNY Upstate. Any other ethical approvals are not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have been advised of publication of this work and none have opposed. No other consents are needed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"W.G.K, S.F., C.P., C.D.S., D.S. and J.D.C have patents, pending and issued, concerning the analysis and targeting of SHIP1 and SHIP2 in disease and infection. The other authors have no interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"314"}}